Page last updated: 2024-10-25

chlorpropamide and Hyperplasia

chlorpropamide has been researched along with Hyperplasia in 2 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rayman, G1
Santo, M1
Salomon, F1
Almog, S1
Paradinas, FJ1
Pinkhas, J1
Reynolds, KW1
Wise, PH1
Stowers, JM1

Other Studies

2 other studies available for chlorpropamide and Hyperplasia

ArticleYear
Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis.
    Journal of clinical pathology, 1984, Volume: 37, Issue:6

    Topics: Adult; Chlorpropamide; Female; Humans; Hyperplasia; Hypoglycemia; Insulin; Islets of Langerhans; Pan

1984
Treatment of subclinical diabetes.
    Advances in metabolic disorders, 1970, Volume: 1

    Topics: Adult; Age Factors; Aged; Chlorpropamide; Female; Glycosuria; Humans; Hyperplasia; Hypoglycemic Agen

1970